Adiponectin ‐expressing Treg‐containing T cell fraction inhibits tumor growth in orthotopically implanted triple‐negative breast cancer

ConclusionsBased on our findings, the T cell fraction comprising adiponectin-expressing Tregs, represents a potential candidate for adoptive cell therapy against TNBC.

Source: Thoracic Cancer - September 7, 2023 Category: Cancer & Oncology Authors: Wakana Chikaishi, Toshiya Higashi, Hirokatsu Hayashi, Yuki Hanamatsu, Manabu Futamura, Nobuhisa Matsuhashi, Chiemi Saigo, Tamotsu Takeuchi Tags: ORIGINAL ARTICLE Source Type: research